OppenheimerFunds’s Kite Pharma, Inc. KITE Stock Holding History

OppenheimerFunds’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-59,296	Closed	-$10.7M	–	1917
2017 Q3	$10.7M	Sell	59,296 -46,437	-44%	-$6.47M	0.01%	730
2017 Q2	$11M	Sell	105,733 -15,277	-13%	-$1.25M	0.01%	721
2017 Q1	$9.5M	Sell	121,010 -40,110	-25%	-$2.48M	0.01%	770
2016 Q4	$7.22M	Buy	161,120 +53,320	+49%	+$2.62M	0.01%	796
2016 Q3	$6.02M	Buy	+107,800	New	+$6.01M	0.01%	803
2015 Q2	–	Sell	-88,037	Closed	-$5.08M	–	987
2015 Q1	$5.08M	Buy	88,037 +2,323	+3%	+$156K	0.01%	828
2014 Q4	$4.94M	Buy	+85,714	New	+$3.61M	0.01%	825

OppenheimerFunds's KITE Position: Q4 2017 in Review

OppenheimerFunds sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 59,296 shares — an estimated $10.7M sold.

OppenheimerFunds first reported a position in KITE in Q4 2014 and held it in 7 quarters. The position peaked at $11M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

OppenheimerFunds reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
OppenheimerFunds sold 59,296 Kite Pharma, Inc. shares in Q4 2017, an estimated $10.7M.
OppenheimerFunds first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 7 quarters.
OppenheimerFunds's Kite Pharma, Inc. position peaked at $11M in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.